Aquyre Biosciences

About

Aquyre Biosciences provides tissue adequacy assessment thru tissue micro-architecture delineation and intracellular data acquisition.

Cambridge,Massachusetts,United States
11 - 50
http://www.lltech.co/

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $5.42M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2007
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Aquyre Biosciences Inc

Aquyre Biosciences provides tissue adequacy assessment thru tissue micro-architecture delineation and intracellular data acquisition. Its Full-Field Optical Coherence Tomography (FFOCT) offers en face (transverse), high resolution, 3D imaging of the tissue micro-architecture, at a resolution of 1μm. FFOCT also allows for depth exploration at different focal planes, without compromising 1μm resolution. While the company's Dynamic Cell Imaging (DCI) enhances the cellular contrast by capturing the residual microscopic intracellular activity and behaviors in freshly excised tissue, without staining or partially destroying the tissue.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$22.56M

Aquyre Biosciences has raised a total of $22.56M in funding over 2 rounds. Their latest funding was raised on Mar 9, 2022 from a Series Unknown round.